Skip to main content

Aerospace Medical Association &
Undersea and Hyperbaric Medical Society

UHMS Track

Monday, June 2

Regency VI

Session A - HBO2 Theory and Mechanisms

2pm-2:30pm
Plenary: Chapter 16, UHMS Indications: Mechanisms of Action: Gerardo Bosco, MD, PhD
2:30pm-2:40pm
A1: Hyperbaric oxygen suppresses inflammatory microparticle production in carbon monoxide poisoned patients and in a murine model: Stephen R. Thom, MD
2:40pm-2:50pm
A2: Composition of Breathing Gas Impacts the Development of Noise Induced Hearing Loss in the Hyperbaric Environment: Elliott Dirr, PhD
2:50pm-3pm
A3: Hyperbaric Oxygen Exposure Oppositely Affects Gene Expression of the SARS-CoV-2 Receptors, Toll-Like Receptor TLR3, Interleukins IL4 and IL10, IKKepsilon, and the transcription factors FOXO1 and NFATC1 via Inverse Regulation of NRF2 and miR-365b-5p Expression in Normal and COPD-Diseased Human Bronchial Epithelial Cells: Eva Yi-Hui Chen, PhD
3pm-3:30pm
Plenary: UHM Fellows: Top articles in Hyperbaric Medicine: Samantha Ni, MD
2pm-3:30pm
Posters (Grand Hall East): A4-A9; B10-B33

Session B - Clinical HBO2

4pm-5pm
Plenary: Evaluation of patients for hyperbaric oxygen treatment, to treat or not to treat. Panel: Lin Weaver, Owen O'Neill, Sandra Wainwright, MD
5pm-5:10pm
B10: Ten sessions of Hyperbaric Oxygen versus sham treatment in patients with Long COVID (HOT-LoCO): A randomized, placebo controlled, double-blind, phase II trial: Anders Kjellberg, MD
5:10pm-5:20pm
B11: Hyperbaric oxygen therapy with and without sodium thiosulfate for treatment of wounds caused by calciphylaxis: A retrospective analysis of the past 20 years: Doris J. Armour, MD
5:20pm-5:30pm
B12: Five-year chronic disease burden and mortality risk in carbon monoxide-poisoned patients, with and without hyperbaric oxygen, compared to patients with wrist fractures abstract: Lindell K. Weaver, MD
4pm-5:30pm
Posters (Grand Hall East): A1-A3; B34-B60

Tuesday, June 3

Regency VI

Session C - Decompression Theory and Mechanisms

2pm-2:30pm
Plenary: Shunted venous bubbles: an update on behaviour and pathogenicity: Simon Mitchell, PhD
2:30pm-2:40pm
C66: Decompression to altitude and from high pressure – a common mechanism for microparticle production and putative site for bubble nucleation: Stephen R. Thom, MD
2:40pm-2:50pm
C67: Neutrophil transcriptomic responses to hyperbaric stress using a human lung-on-a-chip model: Abigail G. Harrell, MS
2:50pm-3pm
C68: Real-time automated detection of venous gas emboli: prospective evaluation of a deep learning pipeline after hyperbaric chamber dives: Arian Azarang, PhD
3pm-3:30pm
Plenary: UHMS STEM Opportunity: Virginie Papadopoulou, PhD

Session D - Diving Medicine

4pm-4:30pm
Plenary: What can blood biomarkers tell us about scuba divers and free divers. Padova’s experience and beyond: Tommaso Antonio Giacon
4:30pm-4:40pm
D74: Effect of pre-dive ketone food products on hyperoxic hyperpnea and CNSOT: Kyle Steinbock, BS
4:40pm-4:50pm
D75: Whole-body nitrogen elimination after diving using an open-circuit indirect measurement method: Sven De Ridder
4:50pm-5pm
D76: Central nervous system oxygen toxicity and core temperature responses to HBO2 during immersion with hypercapnic O2 at 3 ATA and pure O2 at 5 ATA in rats: Courtney Wheelock, PhD
5pm-5:30pm
Plenary: UHM Fellows: Top articles in Undersea Medicine: Jayanth Adusumalli, MD
4pm-5:30pm
Posters (Grand /hall East): B61-B65; C66-C73; D77-D93

Wednesday, June 4

Regency VI

Plenary

8:30am-10am
Plenary: International panel: Vestibular DCI; DEEP; Saturation diving table reviews: Philip Bryson, MBBS; Rosanna Stokes, MD; Dawn Kernagis, MD; Jean-Pierre Imbert, PhD

Session E - HBO2 Operations, Chambers and Equipment

10:30am-11am
Plenary: Extremely Intensive Care – Successful delivery of Hyperbaric ECMO - Ian Millar, MD and Bridget Devaney, MBChB
11am-11:10am
E111: Retrospective cohort study of Microvascular Fluorescence Angiography (MFA) use in hyperbaric oxygen therapy patients following lower extremity amputation complicated by flap ischemia: Benjamin R. Banks, MD
11:10am-11:20am
E112: Additional information obtained from the CMS controlled study employing billing records to report effects and costs of hyperbaric oxygen for Radiation Cystitis: John J. Feldmeier, DO
11:20am-11:30am
E113: Sharpened Romberg Test variability in a randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury: Rosemary Ziemnik, MS

Session F - Clinical Evaluations

11:30am11:40am
F130: Myopic changes persist 6 weeks after hyperbaric oxygen treatment course in monoplace chamber: Joan W Chou, MD
11:40am-11:50am
F131: Ultrasound muscle scans collected during decompression may predict post-dive venous gas emboli loads: Joshua Currens
11:50am-12pm
F132: Divers tend to produce individually consistent venous gas emboli grades after conducting the same dive multiple times: Joshua Currens
10:30am-12pm
Posters (Grand Hall East): C74-C76; D94-D110; E114-E123
2pm-2:30pm
Plenary: Microparticles and work in South Korea - Steve Thom, MD
2:30pm-3:30pm
FDA / Safety Panel: TBD

Thursday, June 5

Regency VI

Plenary

10am-10:45am
Plenary: The most complicated monoplace chamber out of this world: Michael Harrison, MD
10:45am-11:30am
Plenary: Update: engineering and pressure - saturation tunnel working in the extremes: Justin Costello
10am-11:30am
Posters (Grand Hall East): E111-E112; E124-E129; F130-F132

Associates Breakout Session

1:30pm-2pm
Concepts of Human Factors in Diving: Jonathan Langham
2pm-2:30pm
Update on codes and compliance: Gus Gustavson, RN
2:30pm-3pm
Go-No Go survey: Marc Pullis
3:30pm-4:30pm
Common findings or common pitfalls for Hyperbaric Facility Accreditation Panel
4:30pm-5pm
Cultural sensitivity in healthcare related to providing hyperbaric care: Gus Gustavson, RN